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ABSTRACT 
The task of purifying monoclonal antibodies (MAbs) and human recombinant antithrombin III (rATII1) from cell culture 
supematant was carried out using two different approaches, both based on the use of membraneous matrices. The first approach 
employed a strongly acidic and a strongly basic membrane ion exchanger, which were evaluated for their ability to purify 
monoclonal antibodies and the human active recombinant antithrombin III from cell culture supematant. Within minutes gram 
amounts of product could be purified in a high-flux system, specially developed for this purpose, achieving purities of 80% for 
MAbs and 75% for rATII1, respectively. The capacity of the acidic membrane ion exchanger for MAbs was found to be 1 mg/cm’ 
with recoveries up to 96% and that of the basic membrane ion exchanger for rATI was 0.15 mglcm’ with recoveries up to 91%. 
The second approach consisted of using heparin, a mucopolysaccharide with a strong affinity towards ATIII, coupled to 
amine-modified or epoxy-activated membranes by reductive amination, for the purification of rATII1. The AT111 binding 
capacities of the membranes were found to be 91 ~g/crn* for the amine-modified and 39 pg/cm* for the epoxy-activated 
membrane, achieving purities of 75%. The coupling proved to be fairly stable over a period of 5 months and the membranes 
remained operable even after steam sterilization and treatment with sodium dodecyl sulphate. Final purification in both instances 
was carried out by gel filtration. 
INTRODUCTION 
Ion-exchange and affinity chromatography are 
common techniques for the purification and 
preparation of proteins, peptides and enzymes. 
However, using classical soft gels or porous 
particle media as a matrix results in a limitation 
arising from the restriction of mass transport in 
these diffusion-dominated systems [1,2]. A dif- 
ferent approach is the attachment of functional 
groups to the inner surfaces of synthetic mi- 
croporous membranes (Table I). The main ad- 
vantage of using membranes as a matrix is that 
the mass transport is convective and therefore 
avoids the aforementioned limitation of classical 
matrices [1,2]. Other interesting features in addi- 
* Corresponding author. 
tion to the high flow-rate include high adsorption 
rates and binding velocities, no problems arising 
from channelling, bed shift or bed collapse and 
the ease of scale-up and the comfort of using a 
prepacked stabilized matrix. Kroner and co- 
workers [1,2] showed the purification of mono- 
clonal antibodies (MAbs) using protein A/G and 
acidic membrane ion exchangers on an analytical 
scale (single sheets of 13.4 and 42 cm2), using the 
same type of membranes that are discussed in 
this investigation. The isolation of microbial 
enzymes with affinity membranes was described 
by Champluvier et al. [3], Briefs and Kula [4] 
and Kroner et al. [5]. 
The aim of this work was to test new 
prototypes of membrane ion exchangers and 
heparin affinity membranes. Analytical-scale 
purification was carrried out using a 100 cm2 
membrane in a fast protein liquid chromato- 
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Fig. 1. Schematic diagrams of the different housings contain- 
ing the membranes. The syringe top and the membrane 
holder were equipped with single membrane sheets. The 
MO-cm2 unit consisted of a stack of five membrane sheets. 
These three units were used with an FPLC or LC system. 
The membrane in the preparative-scale ion exchanger units is 
pleated, and was used with the HFS. 
graphic (FPLC) system. For preparative-scale 
purification, 1400 and 2400 cm membrane ion 
exchanges were used (Fig. 1). 
A special high-flux system (Fig. 2) was de- 
veloped for optimum use of the preparative 
membrane ion exchanger units (MIEX Q, S). 
This system allows high flow-rates (up to 1200 
Fig. 2. High-flux system (HB) consisting of a gear-wheel 
pump, a UV monitor, a pressure transmitter and special 
valves. A personal computer was equipped with interfaces for 
A/D, D/A and ‘lTL signal transfer. Specially developed 
software offers the opportunity to control the valves and to 
monitor the UV and pressure signals, thus permitting com- 
plete automatisation. The system was developed for optimum 
use of the preparative membrane ion exchanger units and 
allows flow-rates up to 1200 mllmin and a maximum pressure 
of 1.2 bar. 
ml/min) and a change in flow direction, which is 
very important for reducing the elution volume 
and also helps to ,prevent fouling of the mem- 
brane. Corresponding controlling software, al- 
lowing complete automation of the whole 
process, has been developed and is currently 
being tested. 
Heparin, a highly sulphated surface muco- 
polysaccharide (M, 5000-30000) shows affinity 
interactions with many enzymes [6], namely 
enzymes of the nucleic acid metabolism [6], low- 
and high-density lipoproteins [7], lysosomal hy- 
drolases [6] and many factors of the blood 
coagulation cascade [8]. In our case we exploit 
the particularly high aflinity interaction that 
exists between heparin and AT111 [9] by co- 
valently\ coupling the former to a membrane. 
The method of reductive amination [lo] was 
chosen because of its reported ability to couple 
heparin in an oriented and stable manner [ll]. 
EXPERIMENTAL 
Cell culture 
Cell. A rat/mouse hybridoma (HB 58; 
ATCC) and a mouse/mouse hybridoma were 
cultivated. Both cell lines secreted monoclonal 
antibodies type IgG, with an isoelectric point 
pZ 2 7. The recombinant Chinese hamster ovary 
(rCH0) cell line produced human active recom- 
binant antithrombin III (rATII1) [12], a glyco- 
protein which is an important regulator of blood 
coagulation. 
Medium. A serum-free standard medium [13] 
containing human transferrin (10 mg/l), bovine 
insulin (10 mg/l) and bovine albumin (1 g/l) 
complexed with oleic acid as the main protein 
components was used. A lipoprotein fraction 
(Excyte I; Bayer Diagnostic, Munich, Germany) 
was added (1 ml/l). On the 100-l scale and for 
the cultivation of the CHO cell line, albumin was 
omitted. 
Bioreuctors. The cell lines were cultivated in a 
2-l bench-scale perfusion system (Biostat BF 2) 
and in a 100-l bioreactor (Biostat 100 L) (Braun 
Biotech International, Melsungen, Germany). 
p0, was set at 40% air saturation, pH at 7.1, 
stirrer speed at 30 rpm and temperature at 37°C. 
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Membrane ion exchangers 
The studies were performend with Sartobind 
membrane ion exchangers, which were kindly 
supplied by Sartorius (Gettingen, Germany). A 
characterization of the membranes is given in 
Table I. 
The high-flux system (HI’S) (Fig. 2) consists of 
a gear-wheel pump (Watson Marlow 5003 U), a 
UV monitor (Uvicord; Pharmacia, Uppsala, 
Sweden), a pressure transmitter (Kistler Instru- 
ments, Winterthur, Switzerland) and special val- 
ves (Type 700; Biirkert, Ingelfingen, Germany). 
A personal computer was equipped with inter- 
faces for A/D, D/A and TTL signal transfer. 
Specially developed software offering the oppor- 
tunity to control the valves and to monitor the 
UV and pressure signals, thus allowing complete 
automation, has been developed and is currently 
being tested. The system was developed for 
optimum use of the preparative membrane ion 
exchanger units and allows flow-rates up to 1200 
ml/min and a maximum pressure of 1.2 bar. In 
order to reduce the elution volume and to 
prevent fouling, the flow direction was changed 
between loading and the other steps (Fig. 3). 
Sample preparation. In order to bind proteins 
to the- ion exchanger, the conductivity of the 
TABLE I 
CHARACTERISTICS OF 
BRANES S, Q AND A 
THE SARTOBIND MEM- 
Characteristic Value 
Membrane material 
Filtration area 
Type 
Membrane thickness 
Maximum operation 
pressure 
Pore size 
pH stability 
Thermal stability 
Binding capacity 
‘ 
Synthetic opolymer 
12.6,100,1400,2400 cm2 
S = strongly acidic 
(sulphonic acid); 
Q = strongly basic (quatemary 
ammonium); 
A = amine modified 
170-190 pm 
4 bar (400 kPa) 
0.45 pm 
pH 2-13 
121°C 
S = 1 mg IgGlcm’; 
Q-O.15 mg ATIII/cm*; 
A = 91 Mg ATIII/cm* 
h4IBX 
Fig. 3. Process diagram of the I-IFS. Load: the sample is 
filtered through the membrane. Wash I: the membrane is 
washed with buffer A to remove unbound proteins. Wash II: 
a change in the flow direction (back-flush) of buffer A is used 
to prevent fouling of the membrane. Elution: buffer B 
eluates the bound protein. 
supematant had to be reduced from 13 mS/cm 
(normal cell culture medium) to 1.3-1.8 mS/cm. 
In addition, some of the supematants were first 
concentrated by ultrafiltration. To achieve this 
reduction in conductivity, several methods were 
used, including a diafiltration cross-flow system 
(SlOY30, SP20; Amicon, Beverly, MA, USA), 
an electrodialysis system (StanTech, Geesthacht , 
Germany) and simple dilution with water (Fig. 
4). After adjusting the pH to 5.8 for MAbs and 
pH 7 for rATII1, the supematant was passed 
through the S- and Q-type membrane ion ex- 
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Fig. 4. Schematic diagram of the general processes used in 
the production and purification of MAbs and rATII1. The 
different sample preparation steps for the membrane ion- 
exchange chromatography are presented together with the 
purification process employing the amine-modified affinity 
membranes. 
changers, respectively, using the HFS or FPLC 
system. The product was eluted from the mem- 
brane by changing the salt concentration. 
Buffers. For the acidic ion exchanger, buf- 
fer system I was (A) 25 mM %-(N-mor- 
pholino)ethanesulphonic acid) (MES)-10 mM 
NaCl (pH 5.8) and (B) 25 mM MES-250 mM 
NaCl (pH 5.8); buffer system II was (A) 10 mM 
sodium-phosphate-10 mM NaCl p(H 5.8) and 
(B) 10 mM sodium-phosphate-250 mM NaCl 
pH 5.8. For the basic ion exchanger, the buffer 
system was (A) 20 mM Tris-HCl (pH 7) and (B) 
20 mM Tris-HCl-250 mM NaCl (pH 7). 
Cleaning and regeneration. Using 0.2 M 
NaOH (60°C 20 min), the membranes could be 
cleaned without loss of binding capacity [14] and 
were regenerated by washing with buffer A. 
Heparin affinity membranes 
Material. An LC system (Pharmacia Bio- 
systems) consisting of a fraction collector, a UV 
monitor, a recorder and a peristaltic pump was 
used for these studies. The matrix was epoxy- or 
amine-modified synthetic copolymer membranes 
(Sartobind; Sartorius) . 
Coupling procedure with amine-modified mem- 
brane. The amine-modified membrane, a single 
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sheet 4.7 cm in diameter, was washed thoroughly 
with 0.2 M phosphate buffer (pH 7.2), placed in 
a sealed test-tube containing 20mg of heparin 
(sodium salt, from porcine intestinal mucosa, 180 
USP units/mg; Sigma, St. Louis, MO, USA) and 
15 mg of sodium cyanoborohydride (NaCNBH,) 
(Fluka, Buchs, Switzerland) in 5 ml of 0.2 M 
phosphate buffer (pH 7.2) and then allowed to 
mix end-over-end for 8 days at room tempera- 
ture. Completion of the coupling was determined 
by analysing the heparin content of the coupling 
solution by the method of Dubois et al. [15]. 
The remaining NH, groups were acetylated 
according to Baues and Gray [16] with 10 ml of 
acetic anhydride and 20 ml of 0.2 M sodium 
acetate, starting at -20°C and mixed end-over- 
end for 60 min at room temperature. After 
thorough washing in buffer A the membrane was 
placed in a membrane holder (Sartorius), which 
reduced the effective surface area of the mem- 
brane to 12.56 cm*, and equilibrated with 200 ml 
of buffer A for the first run. 
Coupling procedure with epoxy-modified mem- 
brane. The 100 cm* epoxy-modified membrane 
module was placed in a coupling array consisting 
of a peristaltic pump and a reservoir allowing the 
respective solutions to be circulated through the 
membrane. The membrane was washed with 300 
ml of 0.2 M phosphate buffer (pH 7.2) (without 
circulation) and then treated for 3 days with 200 
ml of 0.2 M ethylendiamine (EDA), with the pH 
adjusted to 8.5 in order to prevent damage to the 
casing of the module. The membrane was then 
washed one way with 500 ml of 0.2 M phosphate 
buffer (pH 7.2). The coupling solution, consist- 
ing of 30 mg of heparin (sodium salt, from ovine 
intestinal mucosa, 182 IU/mg; Sigma) and 30 mg 
of NaCNBH, in 9 ml of 0.2 M phosphate buffer 
(pH 7.2) was circulated over the membrane for 5 
days. After 3 days an additional 50 mg of 
NaCNBH, in 1 ml of 0.2 M phosphate buffer 
(pH 7.2) were added. The remaining NH, 
groups were again removed by acetylation. 
Sample run. A typical sample run consisted of 
equilibration with 100 ml of buffer A (10 ml/ 
min) followed by loading of the membrane with 
supematant, pH adjustment to 5.8 (l-10 ml/ 
min), a wash step with 100 ml of buffer A and 
finally elution with buffer B (both 10 ml/mm). 
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Bufleers. The buffers were (A) 20 mM 4-(2- 
hydroxyethyl)-1-piperazineethanesulphonic acid 
(HEPES)-150 mM NaCl (pH 5.8) and (B) 20 
mM HEPES-2.5 M NaCl (pH 7). 
Cleaning. In order to prevent fouling of the 
membrane equilibration, washing and elution 
were always performed in a different flow direc- 
tion to loading, resulting in backflushing of the 
system. Additional cleaning of the membrane 
with 2.5% sodium dodecyl sulphate (SDS) solu- 
tion was also successful and resulted in removal 
of clogging material from the membrane, so that 
the original flow-rates were restored. 
Final purijication. This was carried out using a 
preparative gel filtration column (Superdex 200 
PG; Pharmacia) with a 600-ml gel volume. A 20 
mM phosphate buffer containing 150 mM NaCl 
was used. The flow-rate was set at 6 ml/min. 
Analytical methods 
Antibody concentrations were determined 
using a standard kinetic sandwich enzyme-linked 
immunosorbent assay (ELISA) method or an 
ABICAP affinity column (Abion, Jiilich, Ger- 
many) for rapid analysis. rATI concentrations 
were also determind by kinetic ELISA (Behring 
Werke, Marburg, Germany). Purity was deter- 
mined by SDS-polyacrylamide gel electro- 
phoresis (PAGE) [17] either automatically 
(Phast System; Pharmacia) using silver staining 
[18] or manually (Multiphor II; Pharmacia) using 
Sensi-quant Coomassie Brilliant Blue staining 
[19]. The silver-stained gels were scanned using 
the Gel-Image 1DEVA software (Pharmacia). 
The concentration of heparin in the coupling 
solution was determined using the phenol-based 
method described by Dubois et al. [15]. 
Conversion factor. In order to compare mem- 
braneous and gel matrices with respect to ligands 
and protein bound, a conversion factor, obtained 
from Sartorius [20], equalling 50 cm2 of mem- 
brane surface with 1 ml of gei matrix was used. It 
is also important to note that the 17.35-cm2 
membrane was placed in a filter holder that 
reduced the effective surface area to 12.56 cm2. 
All calculations made refer to these values unless 
stated otherwise. 
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RESULTS AND DISCUSSION 
Purification of MAbs with membrane ion 
exchangers l(X)-cm2 membrane ion exchanger 
In order to find the optimum conditions for 
protein binding to the membrane ion exchanger, 
supernatant feed solutions of various pH and 
ionic strength were applied to a lOO-cm2 module 
(Fig. 5). It was found that a pH of 5.8 and a 
corresponding ionic strength of 1.8 mS/cm2 
yielded the best results (96% recovery). During 
the runs conducted so far over 50 mg of IgG per 
module could be bound employing a maximum 
flow-rate of 30 ml/min. The concentration factor 
was about 50-fold, which is comparable to that of 
other ion-exchange matrices. Most of the al- 
bumin could be separated by gradient elution; 
human transferrin, however, was concentrated 
under the conditions stated above (Fig. 6). 
Preparative purification of MAbs using the HFS 
The capacity of the membrane ion exchanger 
of 1 mg IgG/cm’ (equivalent to 50 mg IgG/ml 
bed volume), as determined with a single filter 
100 
l pH 5 
80 0 pH 5.8 
E 
$ 60 
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1 
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Fig. 5. Relationship between conductivity of the supematant 
and binding of MAbs using the 100-cm2 membrane ion 
exchanger with a flow-rate of 10 ml/mm In each run 7 mg of 
MAbs were applied to the membrane. In order to bind more 
than 90% it was necessary to reduce the conductivity to 
values below 1.8 mS/cm. Buffer systems: 0 = pH 5, 25 mM 
acetic acid-10 mM NaCI; V = pH 5.8,25 mM MISS-10 mM 
NaCl; the MAbs were eiuted with the corresponding buffer 
with 250 m&f NaCl. 
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Fig. 6. Purification of monoclonal antibodies from cell cul- 
ture supematant. Following the diatiltration step the supema- 
tant (9 mg of MAbs) was applied to the membrane ion 
exchanger at a flow-rate of 6 ml/min [buffer system I, MES 
(pH 5.8)]. The binding rate was 95%. Using a gradient from 
0 to 8% B for 20 mitt, impurities were separated. With an 
18% step of buffer B, 90% of the MAbs could be eluted. The 
membrane was flushed with 100% B and washed with buffer 
A. SDS-PAGE (unreduced) shows the purification process. 
Samples were diluted 1:l with buffer. Lanes: 1 = crude cell 
culture supematant (150 ml); 2 = low-molecular-mass marker 
(reduced); 3 = breakthrough (180 ml); 4 = MAbs eluted with 
18% B (23 ml); the last peak contains unknown components 
but no proteins. 
sheet (12.56 cm* effective surface), is very high 
compared with filter materials from other sup- 
pliers. The preparative units could bind up to 
910 mg without any decrease in recovery (larger 
amounts were not determined). Lowering the 
ionic strength of the supematant by method I, II 
or IV (Fig. 4) resulted in binding rates of about 
95% and recovery rates in excess of 80% (Table 
II). The recovery was found to be independent 
of the concentration of the supematant. The 
only exception occurs if the relationship between 
the concentration of the MAbs and the volume 
in which they are dissolved becomes too un- 
favourable. A decrease in the ionic strength by 
simple 1:8 dilution with water (III) resulted in 
lower binding capacities if the feed solution 
exceeded a certain volume (>6 l), but in this 
Fig. 7. SDS-polyacrylamide gradient gel (g-25%) using a 
modified silver stain under unreduced conditions. Isolation of 
MAbs with strongly acidic membrane ion exchanger and gel 
filtration. Lanes: 1 = marker, M, 14000-%000 (reduced); 
2=supematant; 3 = supematant after salt reduction; 4= 
unbound proteins (MIEX); 5=first wash (MIEX); 6= 
concentrated IgG (MIEX); 7 = gel filtration 1 peak; 8 = gel 
filtration 2 peak, purified MAbs. kD = kilodalton. 
instance no expensive membrane step such as 
diafiltration was necessary. The concentration 
factor achieved by the MIEX is still unsatisfac- 
tory in comparison with a common ion ex- 
changer (Table III), but optimization of the ion 
exchanger unit towards smaller elution volumes 
could change that. Up to a flow-rate of 571 
l/m* ah (maximum achieved by the system) the 
binding of the MAbs on the MIEX was better 
than 90%. The concentration of 5 g of IgG in 
several cycles with one unit was possible; sub- 
100 , , 160 
Stsrilisation 
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60 
I 140 
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-80 .E! 
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Number of runs 
Fig. 8. Repeated use of the amine-modified membrane over 
a period of 150 days. Effects of steam sterilization and 
treatment with 2.5% SDS. 
D. Liitkemeyer et al. I J. Chromatogr. 639 (1993) 57-66 
TABLE II 
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SUMMARY OF DIFFERENT SAMPLE PREPARATION STEPS AND THE SUBSEQUENT MEMBRANE ION- 
EXCHANGER RUNS 
Within minutes gram amounts of product could be purified in the I-IFS [buffer system I, sodium phosphate (pH KS)]. The 
concentration factor was calculated by dividing the IgG concentration in the elution by the IgG concentration in the supematant. 
The recovery was found to be independent of the concentration of the supematant. Lowering the ionic strength of the 
supematant by method I, II or IV resulted in binding rates of about 95% and recoveries in excess of 80%. 
Method No. IgG Volume IgG Flow- Recovery Concen- Process Throughput IgG 
(mg) @I) bound rate (%) tration time (g/h) species 
(%) (ml/n@ factor (h) 
(I) Ultratiltration and 
diafiltration 
(II) Diatiltration only 
(III) Dilution of the 
supernatant with 
water 
(IV) Ultrafiltration and 
electrodialyrsis 
1 320 2010 
2 187 5200 
3 319 5500 
4 910 1000 
5 910 1000 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
187 5200 
166 4600 
43 3300 
146 3500 
139 5600 
37 16700 
110 14300 
240 34500 
456 1400 
489 1500 
391 1200 
267 1100 
99 750 81 13.6 0.08 4.0 
95 866 93 10.7 0.14 1.3 
99 845 81 12.7 0.15 2.1 
97 843 84 1.8 0.06 14.3 
99 843 94 2.6 0.06 14.3 
95 866 93 10.7 0.14 1.3 
99 836 96 14.3 0.13 1.3 
95 843 81 8.9 0.11 0.4 
91 845 91 10.3 0.11 1.3 
94 I345 91 17.7 0.15 0.9 
73 843 68 17.2 0.37 0.1 
68 843 66 22.1 0.32 0.3 
63 843 57 122 0.72 0.3 
91 845 90 3.1 0.11 4.2 
91 845 84 4.0 0.11 4.3 
98 845 75 3.0 0.11 3.6 
97 1060 80 4.4 0.08 3.3 
Rat 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
Rat 
Rat 
Rat 
Mouse 
Mouse 
Mouse 
Mouse 
TABLE III 
COMPARISON BETWEEN A GEL-MATRIX CATION 
EXCHANGER (S-SEPHAROSE FF) AND THE 
STRONGLY ACIDIC MEMBRANE ION EXCHANGER 
(SARTOBIND S) 
Parameter 
Bed volume/area 
Supernatant volume (ml) 
Flow-rate (mllmin) 
MAbs applied (mg) 
MAbs bound (%) 
Recovery (%) 
Concentration factor 
Process time (h) 
Throughput (g/h) 
’ Pharmacia, S. 
Matrix 
S-Sepharose FF 
28 ml 
(XX 50 x 30)’ 
4700 
80 
359 
69 
67 
58 
1.50 
0.16 
Sartobind S 
1408 cm’ 
5500 
845 
319 
99 
81 
13 
0.15 
2.10 
sequently a treatment with 0.2 M NaOH (6O”C, 
20 min) restored the flow. So far one MIEX unit 
has been used 25 times without decreases in 
binding capacity, recovery or flow-rate. The 
main advantage of the MIEX in comparison with 
an ion exchanger based on gel matrices is the 
much higher throughput (>13-fold) (Table III). 
Final purification of the MAbs was carried out 
using a preparative gel filtration column. The 
elutions from the MIEX were applied directly, 
without prior concentration, to the gel tiltration 
column and resulted in two distinct peaks. The 
second peak contained the purified MAbs (Fig. 
7). 
Purification of rATIII 
Affinity membranes. The 17.35-cm2 amine- 
modified membrane covalently coupled 5.2 mg 
of heparin (porcine), corresponding to ca. 0.3 
mg heparin/cm2 matrix, which is slightly higher 
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than that obtained by Sasaki et al. (0.2 mg/cm’) 
[ll]. The coupling took fairly long to complete 
(8 days), but this is not uncommon for reductive 
amination [10,21] and the optimized conditions 
that were taken from the paper by Sasaki et al. 
[ll], which were obtained using amino-sepha- 
rose as a matrix, might not apply completely to 
the membraneous matrix used in this instance. 
The maximum amount of rATI that could be 
adsorbed to the amine-modified membrane was 
1.14 mg (Fig. 8), which amounts to a binding 
capacity of 90.8 pg/cm* (effective surface area 
12.56 cm’). This value equals or exceeds that of 
other commercially available heparin affinity 
matrices. The stability achieved by the method 
of reductive amination used in this instance was 
very satisfactory especially when compared with 
the known shortcomings [lo] of products coupled 
by the cyanogen bromide method. The amine- 
based heparin-affinity membrane was used 
eleven times over a period of about 5 months, 
purifying a total of 8.2 mg of rATII1. It was also 
sterilized by steam sterilization (15 min at 114°C) 
after six runs, losing about 38% of its capacity 
(average of the first six runs, 71.7 pg rATIII/ 
cm*; average of the last five runs, 43.9 pg/cm*) 
and treated sucessfully at one time with 2.5% 
SDS solution to remove clogging material from 
the membrane surface. 
The 100~cm* module containing an epoxy- 
activated membrane, which was first treated with 
ethylenediamine in order to produce sufficient 
spacers, coupled 12 mg of heparin (ovine) in 5 
days, which corresponds to 0.18 mg heparin/ 
cm*. The best run resulted in the purification of 
3.95 mg of rATII1, which denotes a binding 
capacity of 39.5 pg/cm*. The lOO-cm* module 
purified a total of 18 mg of rATI in eight runs 
over a period of almost 3 months (Fig. 9). 
The lOO-cm* module lost considerable binding 
capacity (about 65% when comparing the 
average of the first three runs with that of the 
last five) (Fig. 9). This loss might be due to 
storing the filter without first removing the 
clogging material. Treatment with 2.5% SDS 
after the fifth run, however, resulted in an 
improvement of the rATI binding capacity 
(Fig. 9). 
The initial purity of the eluates was about 75% 
0 0 
0 2 4 6 5 10 
Number of runa 
Fig. 9. Repeated use of the epoxy-modified membrane over 
a period of 85 days. Effect of treatment he membrane with 
2.5% SDS. 
5 
(as determined with the Gel-Image system), with 
impurities mainly in the lower-molecular-mass 
range. These non-specific bindings might be due 
to the many affinity interactions of heparin [6], 
or the fact that heparin as a highly sulphated 
saccharide polyanion has some of the properties 
of a cation exchanger. The low-molecular-mass 
protein impurities were readily removed by gel 
filtration (Fig. 10). 
60 
P) 
60 z 
El 
.!A 
40 k 
d 
20 . 
Fig. 10. SDS polyacrylamide gradient gel (g-25%) using a 
modified silver stain under unreduced conditions. Isolation of 
rATI with basic preparative ion exchanger, amine-modified 
afflnity membranes and gel filtration. Lanes: 1 = supematant 
after ultra- and diafiltration (concentrated tenfold); 2= 
marker, M, 14 000-96000 (reduced); 3 + 4 = elution of 
rATI from MIEX Q; 5 = elution of rATI from affinity 
membrane; 6 = pure rATI (after afflnity membrane and 
subsequent gel filtration.) 
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TABLE IV 
CONCENTRATION OF rATI WITH THE STRONGLY 
THEHFS 
BASIC MEMBRANE ION EXCHANGER (2400 cm’) USING 
No. rATI Volume 
(mg) (ml) 
rATI 
bound 
(%) 
Flow-rate Recovery Concentration 
(ml/mitt) (%) factor 
Process 
time 
(h) 
Throughput 
(g/h) 
1 210 2ooo 100 560 99 3.9 0.08 2.6 
2 240 2oml 100 560 99 2.5 0.15 1.5 
3 140 5.50 98 380 98 1.6 0.51 0.3 
4 344 7500 100 580 96 14.4 0.51 0.6 
5 366 8000 100 600 79 11.8 0.47 0.8 
6 113 5ooo 93 610 79 13.1 0.31 0.5 
7 110 3500 85 620 82 11.9 0.22 0.5 
8 68 4500 100 620 98 22.0 0.28 0.3 
9 18 3500 100 620 92 17.8 0.36 0.05 
The affinity of the heparin membranes towards 
human transfer& the most critical contaminant 
in this instance, is very weak. Ionic interactions 
with the matrix were further diminished by 
adjusting the pH of the supernatant o 5.8, the 
isoelectric point of human transferrin. 
Preparative purification of rATZZZ using the 
HFS. The 2400~cm2 units could be run with 
flow-rates up to 620 ml/min, achieving binding 
rates of 97% and recoveries of about 91% (Table 
TABLE V 
COMPARISON OF A GEL-MATRIX ANION EX- 
CHANGER (Q-SEPHAROSE FF) AND THE STRONG- 
LY BASIC MEMBRANE ION EXCHANGER (SAR- 
TOBIND Q) 
Parameter Matrix 
Q-Sepharose FF Sartobind Q 
Bed volume/area 
Supematant volume (ml) 
Flow-rate (ml/min) 
rATI applied (mg) 
rATI bound (%) 
Recovery (%) 
Concentration factor 
Process time (h) 
Throughput (g/h) 
30 ml 
(XX 50 x 30) 
4200 
60 
246 
100 
95 
42 
1.70 
0.15 
2400 cm* 
7500 
580 
344 
loo 
96 
14 
0.51 
0.68 
’ Pharmacia, S. 
IV). The estimated capacity of the anion ex- 
changer membrane for rATI of 0.15 mg/cm2 
(360 mg/unit) is low compared with the capacity 
of the S type for MAbs; this might be due to the 
competive binding of DNA and other negatively 
charged biomolecules under these conditions. 
The purity of the product was 75%, with human 
transferrin as one of the main impurities (Fig. 
10). In comparison with standard ion exchangers 
(Table V), MIEX shows similar binding and 
recovery rates. Only the concentration factor 
(elution volume) could be improved in the fu- 
ture. Purification with MIEX resulted in a 
throughput more than four times higher than 
Q-Sepharose FF. 
CONCLUSIONS 
Membrane ion exchanger and affinity mem- 
branes are versatile tools for the concentration 
and purification of MAbs and rATII1. The 
binding capacity, the recovery and the concen- 
tration factor (only by the lOO-cm2 unit) are 
similar to those for gel matrices. The main 
advantage is the very high throughput. They are 
easy to handle and can be used repeatedly. 
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